1. Home
  2. FULC vs SWBI Comparison

FULC vs SWBI Comparison

Compare FULC & SWBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fulcrum Therapeutics Inc.

FULC

Fulcrum Therapeutics Inc.

HOLD

Current Price

$7.57

Market Cap

462.2M

Sector

Health Care

ML Signal

HOLD

Logo Smith & Wesson Brands Inc.

SWBI

Smith & Wesson Brands Inc.

HOLD

Current Price

$14.38

Market Cap

491.2M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
FULC
SWBI
Founded
2015
1852
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Ordnance And Accessories
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
462.2M
491.2M
IPO Year
2019
2000

Fundamental Metrics

Financial Performance
Metric
FULC
SWBI
Price
$7.57
$14.38
Analyst Decision
Buy
Strong Buy
Analyst Count
8
1
Target Price
$16.38
$14.00
AVG Volume (30 Days)
994.3K
670.3K
Earning Date
04-30-2026
03-05-2026
Dividend Yield
N/A
3.61%
EPS Growth
N/A
N/A
EPS
N/A
0.05
Revenue
N/A
$474,661,000.00
Revenue This Year
N/A
$7.61
Revenue Next Year
N/A
$3.72
P/E Ratio
N/A
$287.80
Revenue Growth
N/A
N/A
52 Week Low
$2.32
$7.73
52 Week High
$15.74
$15.40

Technical Indicators

Market Signals
Indicator
FULC
SWBI
Relative Strength Index (RSI) 48.10 62.59
Support Level $7.40 $13.65
Resistance Level $8.01 $14.51
Average True Range (ATR) 0.43 0.41
MACD 0.10 -0.05
Stochastic Oscillator 78.43 39.43

Price Performance

Historical Comparison
FULC
SWBI

About FULC Fulcrum Therapeutics Inc.

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing small molecules for genetically defined rare diseases. Its product candidate, Pociredir, is an oral small molecule designed to induce fetal hemoglobin (HbF) and is in clinical development for sickle cell disease (SCD). The company completed dosing in the Phase 1b PIONEER trial evaluating pociredir in adults with SCD and reported clinical data showing clinically relevant HbF induction and improvements in markers of hemolysis and anemia. The company has also generated a pipeline of clinical-stage and pre-clinical programs targeting the root causes of rare genetic diseases.

About SWBI Smith & Wesson Brands Inc.

Smith & Wesson Brands Inc is a U.S.-based leader in firearm manufacturing. It operates under one reportable segment: Firearms, which includes firearms distribution and manufacturing services. The company manufactures handguns, long guns, sporting rifles, shooting gear, and suppressor products. The firm's brand portfolio consists of Smith and Wesson, M&P, Thompson/Center Arms, Performance Center, and Gemtech; which are used for defense, law enforcement, hunting, and sporting purposes. The company operates internationally, with the majority of income generated by the U.S. market from its handgun products.

Share on Social Networks: